Study of Trametinib and Nab-paclitaxel in Patients With Melanoma
Clinical trial NCT02300935 · WITHDRAWN
Trial details
- NCT number
- NCT02300935
- Sponsor
- SCRI Development Innovations, LLC
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-01-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.